These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 91724)

  • 21. Multiple sclerosis: immunopathologic mechanisms in the progression and resolution of inflammatory demyelination.
    Raine CS
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():37-54. PubMed ID: 1691521
    [No Abstract]   [Full Text] [Related]  

  • 22. EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis.
    Ransohoff RM
    Trends Immunol; 2006 Apr; 27(4):167-8. PubMed ID: 16513422
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunologic studies of chronic relapsing EAE in guinea pigs: similarities to multiple sclerosis.
    Mehta PD; Lassmann H; Wisniewski HM
    J Immunol; 1981 Jul; 127(1):334-8. PubMed ID: 7240747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Multiple sclerosis. Current status of research. II].
    Lhermitte F; Lyon-Caen O
    Rev Neurol (Paris); 1983; 139(6-7):395-406. PubMed ID: 6612147
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunoglobulins treatment in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Achiron A; Miron S
    Mult Scler; 2000 Oct; 6 Suppl 2():S6-8; discussion S33. PubMed ID: 11188777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility to experimental allergic encephalomyelitis in animal models of autoimmunity.
    Lublin FD
    Curr Opin Neurol Neurosurg; 1992 Apr; 5(2):182-7. PubMed ID: 1377972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Of mice and men: experimental autoimmune encephalitis and multiple sclerosis.
    Handel AE; Lincoln MR; Ramagopalan SV
    Eur J Clin Invest; 2011 Nov; 41(11):1254-8. PubMed ID: 21418205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editorial: Immunologic mysteries of multiple sclerosis.
    Waksman BH
    N Engl J Med; 1974 Jul; 291(1):45-6. PubMed ID: 4832403
    [No Abstract]   [Full Text] [Related]  

  • 29. Multiple sclerosis therapies: molecular mechanisms and future.
    Fontoura P; Garren H
    Results Probl Cell Differ; 2010; 51():259-85. PubMed ID: 20838962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity of oligoclonal IgG bands against myelin proteins in chronic relapsing EAE in guinea pigs.
    Mehta PD; Patrick BA; Mehta SP; Wisniewski HM
    J Immunol; 1987 Feb; 138(3):746-51. PubMed ID: 2433329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD8⁺ T cell help is required for efficient induction of EAE in Lewis rats.
    Camara M; Beyersdorf N; Fischer HJ; Herold MJ; Ip CW; van den Brandt J; Toyka KV; Taurog JD; Hünig T; Herrmann T; Reichardt HM; Weishaupt A; Kerkau T
    J Neuroimmunol; 2013 Jul; 260(1-2):17-27. PubMed ID: 23664330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
    Kassis I; Petrou P; Halimi M; Karussis D
    Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conclusion: is myelin basic protein the right antigen and experimental allergic encephalomyelitis the right model for multiple sclerosis?
    Alvord EC
    Prog Clin Biol Res; 1984; 146():503-8. PubMed ID: 6201920
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
    Ziemssen T; Ziemssen F
    Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple sclerosis: human model for EAE?
    Hohlfeld R
    Eur J Immunol; 2009 Aug; 39(8):2036-9. PubMed ID: 19672899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis.
    Lunin SM; Glushkova OV; Khrenov MO; Novoselova TV; Parfenyuk SB; Fesenko EE; Novoselova EG
    Immunobiology; 2013 Mar; 218(3):402-7. PubMed ID: 22727332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological aspects of demyelinating diseases.
    Martin R; McFarland HF; McFarlin DE
    Annu Rev Immunol; 1992; 10():153-87. PubMed ID: 1375472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
    Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
    Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunological analysis by using animal models of multiple sclerosis--acute and chronic relapsing EAE].
    Tabira T
    Rinsho Shinkeigaku; 1984 Dec; 24(12):1229-31. PubMed ID: 6336039
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.
    Martin R; McFarland HF
    Crit Rev Clin Lab Sci; 1995; 32(2):121-82. PubMed ID: 7598789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.